Decellularized scaffold for cartilage repair as well as preparation method and application of decellularized scaffold
By combining animal cartilage decellularization matrix with lipid compounds and modifying it with phenylalanine dipeptide, an acellular scaffold with excellent piezoelectric properties and good biocompatibility was prepared, and the existing cartilage repair material biological was solved. The problem of poor compatibility achieves the combination of mechanical-electrical stimulation effects, significantly improving the cartilage repair effect.
Patent Information
- Application Number
- CN202410999342.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-24
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-07-24
AI Technical Summary
Existing cartilage repair materials face great challenges in optimizing biological factor delivery and chemical modification, and biomechanical factors have not been paid enough attention to, and the materials have poor biocompatibility and high toxicity, so they cannot achieve clinical application.
Using a decellularized scaffold based on phenylalanine dipeptide or phenylalanine-tryptophan peptide, a double-bonded decellularized matrix is formed by combining animal cartilage decellularized matrix with lipid compounds, and cross-linking is carried out through copolymerization. and dipeptide modification to achieve the combination of mechanical-electrical stimulation effects, achieving excellent piezoelectric properties and good biocompatibility.
The stimulating effect of mechanics-electrical is simultaneously introduced into the stent, which improves piezoelectric performance and biocompatibility, significantly improves the cartilage repair effect, and has clinical application potential.
Smart Images

Figure CN118987352A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the field of biomedicine, and in particular to a decellularized scaffold for cartilage repair and a preparation method and application thereof. Background Art
[0002] Cartilage is avascular and anervous with limited intrinsic regenerative capacity, so external intervention is necessary after injury. Patients often experience pain, and untreated cases can progress to osteoarthritis, which seriously affects mobility and places a heavy burden on families. Current clinical strategies focus primarily on relieving symptoms with analgesics and anti-inflammatory drugs.
[0003] Bioelectricity plays an important role not only in neural function but also in various physiological processes. Collagen, the main protein in the extracellular matrix (ECM) of bone and cartilage, has inherent piezoelectric properties with a piezoelectric coefficient between 0.2 and 2.0 pC / N. Although tissue engineering and microfracture therapy for cartilage repair complement each other, they still face huge challenges in optimizing the delivery of biological factors and chemical modification. Biomechanical factors have not received enough attention throughout history, and their own bioelectric properties have been even more neglected. In addition, existing materials have poor biocompatibility and high toxicity, making them difficult to clinically apply. Summary of the invention
[0004] In view of the problems existing in the background technology, the present application provides a decellularized scaffold for cartilage repair, and its preparation method and application. The decellularized scaffold is based on dipeptides such as phenylalanine dipeptide or phenylalanine-tryptophan peptide, and introduces mechanical and electrical stimulation effects into the scaffold at the same time. It not only has excellent piezoelectric properties, but also has good biocompatibility and repair effects.
[0005] According to a first aspect of the present invention, a method for preparing a decellularized scaffold for cartilage repair is provided, comprising: preparing a decellularized matrix from animal cartilage; chemically bonding the decellularized matrix with a lipid compound to obtain a double-bond modified decellularized matrix; copolymerizing and cross-linking the double-bond modified decellularized matrix to obtain a decellularized matrix hydrogel; and immersing the decellularized matrix hydrogel in a dipeptide solution for modification to obtain a decellularized scaffold.
[0006] The decellularized scaffold of the present invention is based on dipeptide. The animal cartilage decellularized matrix is combined with lipid compounds to obtain a double-bond modified decellularized matrix, and the double-bond modified decellularized matrix is copolymerized and cross-linked to obtain a decellularized matrix hydrogel, which is further modified with dipeptide to finally obtain a piezoelectric decellularized scaffold, thereby achieving the simultaneous introduction of mechanical and electrical stimulation effects into the scaffold. The scaffold not only has excellent piezoelectric properties, but also has good biocompatibility and repair effects.
[0007] In some embodiments of the present invention, the preparation of the decellularized matrix includes: first digesting the animal cartilage in a trypsin solution, then adding DNase and RNase for treatment, then further treating the animal cartilage with a sodium dodecyl sulfate solution and a cell lysis solution, and rinsing it to obtain the decellularized matrix.
[0008] In some embodiments of the present invention, the animal cartilage is porcine femoral knee cartilage.
[0009] In some embodiments of the present invention, the lipid compound includes methacrylic anhydride or glyceryl methacrylate.
[0010] In some embodiments of the present invention, the decellularized matrix and the lipid compound are chemically bonded to obtain a double-bond modified decellularized matrix, comprising: firstly dissolving the decellularized matrix in deionized water, and cooling in an ice water bath to obtain a mixed solution; then adjusting the pH of the mixed solution to alkaline; then dropping the lipid compound into the solution under stirring to react; and then performing dialysis separation to obtain the double-bond modified decellularized matrix.
[0011] In some embodiments of the present invention, the cut-off molecular weight of the dialysis separation is 7000 Da.
[0012] In some embodiments of the present invention, copolymerizing and cross-linking the double-bond modified decellular matrix to obtain a decellular matrix hydrogel includes: first dissolving the double-bond modified decellular matrix in a PBS solution, then adding an initiator, and then irradiating the system under blue light to complete gelation to obtain the decellular matrix hydrogel.
[0013] In some embodiments of the present invention, the dipeptide comprises a phenylalanine dipeptide or a phenylalanine-tryptophan peptide.
[0014] In some embodiments of the present invention, immersing the decellularized matrix hydrogel in a dipeptide solution for modification to obtain a decellularized scaffold includes: preparing a mixed solvent of methanol and water; dissolving a dipeptide in the mixed solvent to obtain a dipeptide solution; immersing the decellularized matrix hydrogel in the dipeptide solution for reaction, then taking it out and freeze-drying it; repeating the process of immersing the decellularized matrix hydrogel in the dipeptide solution, taking it out and freeze-drying it multiple times; and obtaining the decellularized scaffold.
[0015] In some embodiments of the present invention, the concentration of the phenylalanine dipeptide solution is 8 mg / mL.
[0016] According to a second aspect of the present invention, a decellularized scaffold for cartilage repair prepared by the above-mentioned preparation method is provided.
[0017] According to a third aspect of the present invention, there is provided a decellularized scaffold prepared by the above-mentioned preparation method or use of the above-mentioned decellularized scaffold in preparing a cartilage repair material. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Various other advantages and benefits will become apparent to those of ordinary skill in the art by reading the detailed description of the preferred embodiments below. The accompanying drawings are only for the purpose of illustrating the preferred embodiments and are not to be considered as limiting the present application. Also, the same reference symbols are used throughout the accompanying drawings to represent the same components. In the accompanying drawings:
[0019] Figure 1 This is a pressure-current test diagram of different decellularized scaffold materials of the present invention. Figure 1 (A) The decellularized scaffold material was not piezoelectrically modified. Figure 1 (B) Decellularized scaffold material was modified by piezoelectricity;
[0020] Figure 2 This is a pressure-voltage test diagram of the decellularized scaffold modified with phenylalanine dipeptide of the present invention;
[0021] Figure 3 This is a biocompatibility test diagram of different decellularized scaffold materials of the present invention. Figure 3 (A) The decellularized scaffold material was not piezoelectrically modified. Figure 3 (B) Decellularized scaffold material was modified by piezoelectricity;
[0022] Figure 4 This is a test diagram of the implantation effect of different decellularized scaffold materials of the present invention. Figure 4 (A) The decellularized scaffold material was not piezoelectrically modified. Figure 4 (B) Decellularized scaffold material was modified by piezoelectric. DETAILED DESCRIPTION
[0023] The present invention will be further described below with reference to specific embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the scope of the present invention. Those skilled in the art will easily recognize multiple non-critical parameters, which can be changed or modified, and the results are substantially the same.
[0024] If no specific technology or conditions are specified in the examples, the technology or conditions described in the literature in this field or the product instructions are used. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased through regular channels. The experimental methods in the following examples are all conventional methods unless otherwise specified. The test materials used in the following examples are all commercially available products unless otherwise specified.
[0025] Commonly used inorganic materials in contemporary research include salts containing heavy metal ions, such as barium titanate (BaTiO3), which has excellent piezoelectric properties, however, its poor biodegradability and low doping level limit its applicability for in vivo implantation. Similarly, the piezoelectric properties of poly-L-lactic acid (PLLA) are not ideal, and the acidic metabolites produced by its decomposition can induce an inflammatory response at the implantation site, thereby affecting the efficacy. In addition, traditional piezoelectric polymers, such as polyvinylidene fluoride-trifluoroethylene (PVDF-TrFE), require high voltage polarization and are not degradable.
[0026] Phenylalanine is an essential amino acid for the human body. It can self-assemble into diphenylalanine (FF) to form a hexagonal structure with strong piezoelectric properties and a piezoelectric coefficient d33 value of 18 pm / V. Phenylalanine dipeptide is used in the field of sensors, and due to its biocompatibility and degradability, although it has not yet been developed in the medical field, it has great potential in clinical applications.
[0027] A first aspect of the present invention provides a method for preparing a decellularized scaffold for cartilage repair, the method comprising the following steps:
[0028] 1) Decellularization of materials.
[0029] The animal cartilage is taken to prepare the decellularized matrix: the animal cartilage is first digested in a trypsin solution, and then treated with DNase and RNase, and then further treated with a sodium dodecyl sulfate solution and a cell lysis solution, and then rinsed to obtain the decellularized matrix.
[0030] In some embodiments of the present invention, the animal cartilage includes but is not limited to porcine femoral knee cartilage.
[0031] Furthermore, the pig femur is preferably fresh pig femur, specifically taken from pig femur after slaughter in a slaughterhouse.
[0032] In some embodiments of the present invention, after being treated with the sodium dodecyl sulfate solution and the cell lysis solution, the animal cartilage is rinsed with pure water until there is no foam.
[0033] Furthermore, pure water includes but is not limited to distilled water, deionized water, etc.
[0034] Furthermore, the animal cartilage was stirred using a magnetic stirrer at a rotation speed of 210 rpm.
[0035] In some embodiments of the present invention, the animal cartilage is rinsed, freeze-dried and ground into powder using a mechanical grinder.
[0036] 2) Modification with methacrylic anhydride or glyceryl methacrylate.
[0037] The decellularized matrix is chemically bonded with lipid compounds such as methacrylic anhydride or methacrylate glyceride to obtain a double-bond modified decellularized matrix: first, the decellularized matrix is dissolved in deionized water and cooled in an ice water bath to obtain a mixed solution; then the pH of the mixed solution is adjusted to alkaline; then, under stirring, methacrylic anhydride or methacrylate glyceride is dropped into the solution for reaction; and then dialysis separation is performed to obtain the double-bond modified decellularized matrix.
[0038] In some embodiments of the present invention, the pH value of the mixed solution is adjusted by sodium hydroxide.
[0039] Furthermore, the pH value of the mixed solution is adjusted to 8.
[0040] In some embodiments of the invention, the molecular weight cut-off for dialysis separation is 7000 Da.
[0041] 3) Preparation of decellularized extracellular matrix hydrogel.
[0042] Decellularized matrix hydrogel was prepared by gradient freezing and photocrosslinking: first, the double-bond modified decellularized matrix was dissolved in PBS solution, then an initiator was added, and then the system was irradiated under blue light to complete gelation and obtain the decellularized matrix hydrogel.
[0043] In some embodiments of the present invention, a bridge agent is added as an initiator to the PBS solution to which the double-bond-modified decellularized matrix is added.
[0044] Furthermore, the bridge material is phenyl-2,4,6-trimethylbenzoyl lithium phosphite.
[0045] In some embodiments of the present invention, the PBS solution to which the double-bond modified decellularized matrix is added is placed in a freezing environment to form a freezing system, and the freezing system is irradiated under blue light.
[0046] Furthermore, the gradient freezing system is first at 4°C for 30 min, -20°C for 2 h, and after photo-crosslinking and sufficient swelling, at -80°C for 12 h.
[0047] 4) Dipeptide modification.
[0048] The decellularized matrix hydrogel is immersed in a dipeptide solution such as phenylalanine dipeptide or phenylalanine-tryptophan peptide for modification to obtain a piezoelectric decellularized scaffold: a mixed solvent of methanol and water is prepared; phenylalanine dipeptide or phenylalanine-tryptophan peptide is dissolved in the mixed solvent to obtain a phenylalanine dipeptide solution or a phenylalanine-tryptophan peptide solution; the decellularized matrix hydrogel is immersed in the phenylalanine dipeptide solution or the phenylalanine-tryptophan peptide solution for reaction, then taken out and freeze-dried; the process of immersing the decellularized matrix hydrogel in the phenylalanine dipeptide solution or the phenylalanine-tryptophan peptide solution, taking out and freeze-drying is repeated three times; and a piezoelectric decellularized scaffold is obtained.
[0049] In some embodiments of the present invention, the concentration of the phenylalanine dipeptide solution is 8 mg / mL.
[0050] The piezoelectric decellularized scaffold of the present invention is based on phenylalanine dipeptide or phenylalanine-tryptophan peptide. The animal cartilage decellularized matrix is combined with methacrylic anhydride or methacrylate glyceride to obtain a double-bond modified decellularized matrix, and the double-bond modified decellularized matrix is copolymerized and cross-linked to obtain a decellularized matrix hydrogel, which is further modified with phenylalanine dipeptide or phenylalanine-tryptophan peptide to finally obtain a piezoelectric decellularized scaffold, which realizes the simultaneous introduction of mechanical and electrical stimulation effects into the scaffold. The scaffold not only has excellent piezoelectric properties, but also has good biocompatibility and repair effects.
[0051] The second aspect of the present invention provides a decellularized scaffold for cartilage repair, and the decellularized scaffold is prepared by the preparation method provided by the first aspect of the present invention.
[0052] The third aspect of the present invention provides an application of a decellularized scaffold for cartilage repair in the preparation of cartilage repair materials, which is a decellularized scaffold prepared by the preparation method provided by the first aspect of the present invention or a decellularized scaffold provided by the second aspect of the present invention.
[0053] The preparation method of the decellularized scaffold for cartilage repair in the present invention will be further described below in conjunction with specific examples.
[0054] Example 1
[0055] Preparation of Piezoelectric Decellularized Porcine Femoral Knee Cartilage Scaffolds
[0056] (1) Material decellularization process: Fresh porcine femoral knee cartilage was obtained from slaughterhouse, digested with 0.2% trypsin at 4°C for 24 hours, then treated with 0.05‰ DNase and 0.05‰ RNase at 37°C for 24 hours, and then treated with 1% (w / v) sodium dodecyl sulfate (SDS) and 1% Trion X-100 for 72 hours, rinsed with distilled water until there was no foam, and the decellularized cartilage slices were then stirred with a magnetic stirrer at 210 rpm.
[0057] (2) Double bond cross-linking modification process: 3 g of dECM (decellularized matrix) powder was dissolved in 100 ml of deionized water and cooled in an ice water bath. The pH value of the mixed solution was adjusted to 8 with NaOH. Under stirring, 3 mL of methacrylic anhydride was dropped into the solution. The reaction was stopped after 24 hours. The solution was then dialyzed for 3 days with a cutoff molecular weight of 7000 Da. After freeze-drying, double bond-modified dECM was obtained. Then, 3 g of modified dECM powder was dissolved in 300 ml of PBS solution, and 0.3 g of the bridge agent was added as an initiator. The frozen system was then irradiated under 405 nm blue light with a power of 5 W for 5 minutes to complete gelation and obtain a hydrogel.
[0058] (3) Modification of phenylalanine dipeptide: A mixed solvent of methanol and water was prepared with a ratio of methanol to water equal to 3:1 to dissolve phenylalanine dipeptide. The concentration of phenylalanine dipeptide was 8 mg / mL. After hydrogel formation and freeze-drying, the double-bond modified cross-linked decellularized matrix (hydrogel) was immersed in the phenylalanine dipeptide solution for 6 hours. Subsequently, they were taken out and freeze-dried again. This process was repeated three times.
[0059] Example 2
[0060] Material piezoelectric performance test
[0061] The piezoelectric decellularized scaffold of porcine femoral knee cartilage prepared in Example 1 and the decellularized scaffold of porcine femoral knee cartilage prepared only by steps (1) and (2) of Example 1 were used to test the piezoelectric properties of the materials.
[0062] To measure the conductivity, the fully swollen hydrogel (d = 15 mm, h = 4 mm) was placed in a compression device and subjected to compression tests at a frequency of 1 Hz and a strain rate of 20%. The voltage and current outputs were collected using an electrometer (Tektronix 6514, China). To test the stability of the piezoelectric output of the hydrogel, it was immersed in a PBS solution at 37 ° C. The material was then removed at 0, 7, and 14 days, and the piezoelectric test was repeated under cyclic compression conditions.
[0063] like Figure 1 As shown, Figure 1(A) In the case of material without phenylalanine dipeptide modification, the current output under pressure was found to fluctuate within a small range and had no obvious effect; Figure 1 (B) After modification with the phenylalanine dipeptide group, the current output increased rapidly and remained basically stable, reflecting a significant improvement in electrical output.
[0064] like Figure 2 As shown, Figure 2 The hydrogel modified with phenylalanine dipeptide showed a stable voltage range on the pressure-electric output meter, and the piezoelectric properties could be maintained for a long time under treatment at a frequency of 1 Hz, indicating the stability of the modification.
[0065] Example 3
[0066] Biocompatibility test of piezoelectrically modified hydrogels
[0067] The piezoelectric decellularized scaffold of porcine femoral knee cartilage prepared in Example 1 and the decellularized scaffold of porcine femoral knee cartilage prepared only by steps (1) and (2) of Example 1 were tested for biocompatibility.
[0068] like Figure 3 As shown, Figure 3 (A) Unmodified hydrogel (B) Phe dipeptide-modified hydrogel. There is no significant difference in the cell migration effect between the two, indicating that Phe dipeptide has good biocompatibility.
[0069] Example 4
[0070] Implantation effect test of piezoelectric modified hydrogel in miniature pig knee joint
[0071] The piezoelectric decellularized scaffold of porcine femoral knee cartilage prepared in Example 1 and the decellularized scaffold of porcine femoral knee cartilage prepared only by steps (1) and (2) of Example 1 were used to test the implantation effect.
[0072] like Figure 4 As shown, Figure 4 (A) The repair effect of the hydrogel without piezoelectric modification on the huge defect of the miniature pig knee joint after 24 weeks, and the presence of cavities can be clearly observed; Figure 4 (B) The hydrogel with piezoelectric properties not only completed the filling of the defect but also achieved the healing of new cartilage 24 weeks after implantation.
[0073] The above is only a preferred specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any changes or substitutions that can be easily thought of by a person skilled in the art within the technical scope disclosed by the present invention should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims
1. A method for preparing a decellularized scaffold for cartilage repair, characterized in that: include: Animal cartilage is taken to prepare acellular matrix; The decellularized matrix is combined with a lipid compound through chemical bonds to obtain a double-bond modified decellularized matrix; The double-bond modified decellular matrix is copolymerized and cross-linked to obtain a decellular matrix hydrogel; the decellular matrix hydrogel is immersed in a dipeptide solution for modification to obtain a decellular scaffold.
2. The preparation method according to claim 1, characterized in that: The preparation of the decellularized matrix comprises: First, the animal cartilage is digested in a trypsin solution, and then treated with DNA enzyme and RNA enzyme. After that, the animal cartilage is further treated with a sodium dodecyl sulfate solution and a cell lysis solution, and then rinsed to obtain the decellularized matrix.
3. The preparation method according to claim 1, characterized in that: The lipid compound includes methacrylic anhydride or methacrylate glycerol.
4. The preparation method according to claim 1, characterized in that: The double bond modified decellular matrix obtained by chemically bonding the decellularized matrix with lipid compounds includes: First, the decellularized matrix is dissolved in deionized water and cooled in an ice water bath to obtain a mixed solution; then the pH of the mixed solution is adjusted to alkaline; then, lipid compounds are dropped into the solution under stirring to react; and then dialysis separation is performed to obtain the double bond modified decellularized matrix.
5. The preparation method according to claim 4, characterized in that: The molecular weight cut-off for the dialysis separation was 7000 Da.
6. The preparation method according to claim 1, characterized in that: The decellularized matrix hydrogel obtained by copolymerizing and cross-linking the double bond modified decellularized matrix comprises: Firstly, the double-bond modified decellularized matrix is dissolved in a PBS solution, and then an initiator is added, and then the system is irradiated under blue light to complete gelation, thereby obtaining the decellularized matrix hydrogel.
7. The preparation method according to claim 1, characterized in that: The dipeptide includes phenylalanine dipeptide or phenylalanine-tryptophan peptide.
8. The preparation method according to claim 1, characterized in that: The decellularized matrix hydrogel is immersed in a dipeptide solution for modification to obtain a decellularized scaffold comprising: A mixed solvent of methanol and water is prepared; a dipeptide is dissolved in the mixed solvent to obtain a dipeptide solution; a decellularized matrix hydrogel is immersed in the dipeptide solution for reaction, then taken out and freeze-dried; the process of immersing the decellularized matrix hydrogel in the dipeptide solution, taking out and freeze-drying is repeated multiple times; and the decellularized scaffold is obtained.
9. A decellularized scaffold for cartilage repair prepared by the preparation method according to any one of claims 1 to 8.
10. Use of the decellularized scaffold prepared by the preparation method according to any one of claims 1 to 8 or the decellularized scaffold according to claim 9 in preparing cartilage repair materials.
Citation Information
Patent Citations
Cartilage tissue engineering repair bracket and preparation method thereof
CN103877616A
Injectable decellularized scaffold for cartilage repair as well as preparation method and application of injectable decellularized scaffold
CN112807489A
Phenylalanine dipeptidyl co-self-assembly product as well as preparation method and application thereof
CN113629183A
Photosensitive cartilage acellular matrix hydrogel material as well as preparation method and application thereof
CN115475279A
Composite fiber membrane with superelasticity and high piezoelectric property and preparation method thereof
CN117535879A
